Biología Molecular del VIH

Vecino, R; Santiago, B; Baquero-Artigao, F; Lopez, GL; Garcia, C; Munoz, G; Prieto, G; Martinez, A; de Jose, MI; Mejias, A.

TUBERCULOSIS IN PEDIATRIC SOLID ORGAN AND HEMATOPOIETIC STEM CELL; TRANSPLANT RECIPIENTS

PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2012; 31(7): 774-777 Nº de citas: 13 [doi:10.1097/INF.0b013e3182564ec7]

Gras, R; Garcia, MI; Gomez, R; de la Mata, FJ; Munoz-Fernandez, MA; Lopez-Fernandez, LA.

Carbosilane Dendrimer 2G-NN16 Represses Tc17 Differentiation in Primary T CD8+ Lymphocytes

MOLECULAR PHARMACEUTICS. 2012; 9(1): 102-110 Nº de citas: 9 [doi:10.1021/mp200305u]

Relloso, M; Aragoneses-Fenoll, L; Lasarte, S; Bourgeois, C; Romera, G; Kuchler, K; Corbi, AL; Munoz-Fernandez, MA; Nombela, C; Rodriguez-Fernandez, JL; Diez-Orejas, R.

Estradiol impairs the Th17 immune response against Candida albicans

JOURNAL OF LEUKOCYTE BIOLOGY. 2012; 91(1): 159-165 Nº de citas: 34 [doi:10.1189/jlb.1110645]

del Palacio, M; Alvarez, S; Munoz-Fernandez, MA.

HIV-1 infection and neurocognitive impairment in the current era

REVIEWS IN MEDICAL VIROLOGY. 2012; 22(1): 33-45 Nº de citas: 47 [doi:10.1002/rmv.711]

Rasines, B; Sanchez-Nieves, J; Molina, IT; Guzman, M; Munoz-Fernandez, MA; Gomez, R; de la Mata, FJ.

Synthesis and fluorescent properties of cationic carbosilane dendrimers containing eugenol linkers for their use in biomedical applications

NEW J CHEM. 2012; 36(2): 360-370 Nº de citas: 15 [doi:10.1039/c1nj20374f]

Jimenez, JL; Pion, M; de la Mata, FJ; Gomez, R; Munoz, E; Leal, M; Munoz-Fernandez, MA.

Dendrimers as topical microbicides with activity against HIV

NEW J CHEM. 2012; 36(2): 299-309 Nº de citas: 41 [doi:10.1039/c1nj20396g]

Jimenez, JL; Gomez, R; Briz, V; Madrid, R; Bryszewsk, M; de la Mata, FJ; Munoz-Fernandez, MA.

Carbosilane dendrimers as carriers of siRNA

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY. 2012; 22(1): 75-82 Nº de citas: 15 [doi:10.1016/S1773-2247(12)50007-9]

Garcia-Gallego, S; Rodriguez, JS; Jimenez, JL; Cangiotti, M; Ottaviani, MF; Munoz-Fernandez, MA; Gomez, R; de la Mata, FJ.

Polyanionic N-donor ligands as chelating agents in transition metal complexes: synthesis, structural characterization and antiviral properties against HIV

DALTON T. 2012; 41(21): 6488-6499 Nº de citas: 18 [doi:10.1039/c2dt11793b]

Rasines, B; Sanchez-Nieves, J; Maiolo, M; Maly, M; Chonco, L; Jimenez, JL; Munoz-Fernandez, MA; de la Mata, FJ; Gomez, R.

Synthesis, structure and molecular modelling of anionic carbosilane dendrimers

DALTON T. 2012; 41(41): 12733-12748 Nº de citas: 53 [doi:10.1039/c2dt31099f]

Gutierrez, C; Diaz, L; Vallejo, A; Hernandez-Novoa, B; Abad, M; Madrid, N; Dahl, V; Rubio, R; Moreno, AM; Dronda, F; Casado, JL; Navas, E; Perez-Elias, MJ; Zamora, J; Palmer, S; Munoz, E; Munoz-Fernandez, MA; Moreno, S.

Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected

PLoS One. 2011; 6(12): Nº de citas: 85 [doi:10.1371/journal.pone.0027864]

Gomez, CE; Najera, JL; Perdiguero, B; Garcia-Arriaza, J; Sorzano, COS; Jimenez, V; Gonzalez-Sanz, R; Jimenez, JL; Munoz-Fernandez, MA; de Quiros, JCLB; Guardo, AC; Garcia, F; Gatell, JM; Plana, M; Esteban, M.

The HIV/AIDS Vaccine Candidate MVA-B Administered as a Single Immunogen in Humans Triggers Robust, Polyfunctional, and Selective Effector Memory T Cell Responses to HIV-1 Antigens

JOURNAL OF VIROLOGY. 2011; 85(21): 11468-11478 Nº de citas: 68 [doi:10.1128/JVI.05165-11]

Sobrino-Vegas, P; Gutierrez, F; Berenguer, J; Labarga, P; Garcia, F; Alejos-Ferreras, B; Munoz, MA; Moreno, S; del Amo, J.

The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2011; 29(9): 645-653 Nº de citas: 119 [doi:10.1016/j.eimc.2011.06.002]

Garcia, F; de Quiros, JCLB; Gomez, CE; Perdiguero, B; Najera, JL; Jimenez, V; Garcia-Arriaza, J; Guardo, AC; Perez, I; Diaz-Brito, V; Conde, MS; Gonzalez, N; Alvarez, A; Alcami, J; Jimenez, JL; Pich, J; Arnaiz, JA; Maleno, MJ; Leon, A; Munoz-Fernandez, MA; Liljestrom, P; Weber, J; Pantaleo, G; Gatell, JM; Plana, M; Esteban, M.

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pot and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

VACCINE. 2011; 29(46): 8309-8316 Nº de citas: 81 [doi:10.1016/j.vaccine.2011.08.098]

Ruiz-Mateos, E; Gonzalez-Serna, A; Genebat, M; Machmach, K; Vidal, F; Munoz-Fernandez, A; Ferrando-Martinez, S; Leal, M.

Virological Response after Short-Term CCR5 Antagonist Exposure in HIV-Infected Patients: Frequency of Subjects with Virological Response and Associated Factors

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2011; 55(10): 4664-4669 Nº de citas: 14 [doi:10.1128/AAC.00753-11]

de Mulder, M; Yebra, G; Martin, L; Prieto, L; Mellado, MJ; Rojo, P; Munoz-Fernandez, MA; de Ory, SJ; Ramos, JT; Holguin, A.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(10): 2362-2371 Nº de citas: 17 [doi:10.1093/jac/dkr305]

Ferrando-Martinez, S; Leal, M; Gonzalez-Escribano, MF; Vega, Y; Ruiz-Mateos, E.

Simplified sequence-specific oligonucleotide-based polymerase chain reaction protocol to characterize human major histocompatibility complex A*02 and A*24 specificities

HUMAN IMMUNOLOGY. 2011; 72(10): 869-871 Nº de citas: 4 [doi:10.1016/j.humimm.2011.05.025]

Santos, A; Clemente, S; Bartolo, I; Palladino, C; Cavaco-Silva, P; Franco, V; Epalanga, M; Pinto, R; Taveira, N.

Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2011; 71(1): 90-92 Nº de citas: 5 [doi:10.1016/j.diagmicrobio.2011.06.002]

Briz, V; Palladino, C; Navarro, ML; de Ory, SJ; Gonzalez-Tome, MI; Leon, JA; Nunez-Cuadros, E; de Jose, MI; Ramos, JT; Munoz-Fernandez, MA.

Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients

HIV MEDICINE. 2011; 12(7): 442-446 Nº de citas: 17 [doi:10.1111/j.1468-1293.2010.00907.x]